<sup id="mi6k2"><center id="mi6k2"></center></sup><optgroup id="mi6k2"></optgroup>
<optgroup id="mi6k2"></optgroup>
<optgroup id="mi6k2"><div id="mi6k2"></div></optgroup>
<optgroup id="mi6k2"><div id="mi6k2"></div></optgroup>
Download 中文 English
Shanghai ForeFront Pharmaceutical Co., Ltd.
Address: 1st Floor West, Building 7, No. 249, Faladi Road Zhangjiang Hi-Tech Park Shanghai Pudong, China
Email: contactus@forefrontpharma.com
Website: www.eezzp.com

Professor Chen Jiang, Ph.D.

Prof. Jiang graduated from Shanghai Medical University and got her Ph.D in Japanese National Kyushu University. She is the Head of Education & Reaearch Office on Pharmaceutical sciences, Associate Director of the Key Laboratory of Smart Drug Delivery, Ministry of Education in Fudan University. She has over 20 years of experience in pharaceutical research and development. Her research field covers Targeted Nano-Scaled Drug Delivery System, Drug Carrier based on Biomacromolecule and Related Drug Delivery System, Research & Development of New Drug Formulation. She participated in National Important Project on Science (973) including “Research on Guided Nano Drug Carrier System and Its Application in Diagnosis and Therapy in Brain Diseases (No. 2007CB935800)” and “New Nanomedicine Applied in Therapy for Brain Tumors (2013CB932500)”.


Professor Eric Fillion

Eric Fillion received his BSc degree in biochemistry from the Université de Sherbrooke. After completing his MSc degree in medicinal chemistry at the Université de Montréal with Prof. Denis Gravel, he pursued his doctoral studies at the University of Toronto under the direction of Prof. Mark Lautens. From 1998-2000, he was an NSERC post-doctoral fellow in the laboratories of Prof. Larry E. Overman at the University of California, Irvine. In 2000, he joined the Department of Chemistry at the University of Waterloo, where he is currently a Professor of Chemistry. Since starting his independent career, Fillion has received the Early Research Award from the Government of Ontario, the Astra Zeneca Award in Chemistry, the Boehringer Ingelheim Young Investigator Award for Organic Chemistry, the Research Corporation Research Innovation Award, and the 2011 Canadian Society for Chemistry Merck Frosst Centre for Therapeutic Research Award. The Fillion group has developed a number of transition metal- and Lewis acid-catalyzed carbon-carbon bond forming methods; including enantioselective conjugate alkylation, alkenylation, and alkynylation reactions, as well as intramolecular Friedel-Crafts acylation and alkylation reactions. The synthesis of structurally diverse carbocycles and heterocycles using Lewis acid-catalyzed domino reactions of highly electrophilic alkylidenes was also reported by his laboratories. Most recently, his group has explored the stereoselective modification and functionalization of sp3-hybridized carbon centers by cleavage of unstrained carbon-carbon bonds, and the B(C6F5)3-promoted conjugate addition of alkyl-tricarbastannatranes.

Professor Tomislav Rovis
Tomislav Rovis was born in Zagreb, Croatia but raised in Canada. He received his Ph.D. degree with Professor Mark Lautens at the University of Toronto. He was then an NSERC postdoctoral fellow with Professor David A. Evans at Harvard University. In 2000, he began his independent career at Colorado State University. He was promoted to Associate Professor in 2005 and Professor of John K. Stille Chair in 2008. He joined Columbia University in Jul. 2016. His group's accomplishments have been recognized by a number of awards including a GSK Scholar, Amgen Young Investigator, Lilly Granteeship, Montfort Professorship, Roche Excellence in Chemistry, Fellow of the American Association for the Advancement of Science, Katritzky Young Investigator Award of the International Society for Heterocyclic Chemistry and an Arthur C. Cope Scholar.

My status Mr. Zhang